|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02659 BAO PHARMA-B
Nominal 
14.420 -0.480 (-3.221%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Turnover | 9,875 | -76.482% | 49,156 | 6,160 | 6,930 |
| Cost of Sales | (537) | 102.642% | (5,405) | (1,140) | (149) |
| Gross Profit | 9,338 | -77.620% | 43,751 | 5,020 | 6,781 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | (25,193) | (5,566) | -- | |
| Share of Results of Asso. & JCEs | (54) | -52.632% | (238) | (609) | (915) | |
| Profit / (Loss) before Taxation | (153,685) | -16.063% | (395,302) | (364,456) | (160,396) | |
| Taxation | 0 | -- | 0 | 23 | 1 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (153,685) | -16.063% | (395,302) | (364,433) | (160,395) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (6,377) | 589.405% | (166) | (90) | (4,241) |
| Depreciation & Amortisation | 20,210 | 18.924% | 37,148 | 32,136 | 22,434 |
| Directors' Emoluments | -- | -- | -- | 101,861 | 4,068 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | |
| EPS (cts) | -47.000 | -26.563% | -136.000 | -136.000 | -317.000 |
| DPS (cts) | 0.000 | -- | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.620) | (0.821) | (2.771) |
| NBV per share ($) | 4.445 | -- | 4.884 | -- | -- |
| Remarks: | Real time quote last updated: 11/09/2026 10:23 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -153,685 |
| %Change | -16.063% |
| EPS / (LPS) | RMB -0.470 |
| NBV Per Share (¥) | RMB 4.445 |